Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroups

• Main Authors: Yingyong Ou (Author), Zhiwei Cui (Author), Siyu Lou (Author), Chengyu Zhu (Author), Junyou Chen (Author), Linmei Zhou (Author), Ruizhen Zhao (Author), Li Wang (Author), Fan Zou (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

ObjectiveTirzepatide, a novel GIP and GLP1 agonist, has been extensively examined in clinical trials. However, specific data on its adverse drug events (ADEs) remain limited. This study aims to comprehensively assess real-world ADEs associated with tirzepatide by mining data from the U.S. Food and D...